0001140361-21-000393.txt : 20210106
0001140361-21-000393.hdr.sgml : 20210106
20210106202139
ACCESSION NUMBER: 0001140361-21-000393
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210104
FILED AS OF DATE: 20210106
DATE AS OF CHANGE: 20210106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Garcia-Parada Carlos
CENTRAL INDEX KEY: 0001839342
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36829
FILM NUMBER: 21512581
MAIL ADDRESS:
STREET 1: C/O ROCKET PHARMACEUTICALS, INC.
STREET 2: 350 FIFTH AVENUE SUITE 7530
CITY: NEW YORK
STATE: NY
ZIP: 10118
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ROCKET PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001281895
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 350 FIFTH AVENUE
STREET 2: SUITE 7530
CITY: NEW YORK
STATE: NY
ZIP: 10118
BUSINESS PHONE: 646-440-9100
MAIL ADDRESS:
STREET 1: 350 FIFTH AVENUE
STREET 2: SUITE 7530
CITY: NEW YORK
STATE: NY
ZIP: 10118
FORMER COMPANY:
FORMER CONFORMED NAME: INOTEK PHARMACEUTICALS CORP
DATE OF NAME CHANGE: 20040226
4
1
form4.xml
FORM 4
X0306
4
2021-01-04
0001281895
ROCKET PHARMACEUTICALS, INC.
RCKT
0001839342
Garcia-Parada Carlos
C/O ROCKET PHARMACEUTICALS, INC.
9 CEDARBROOK DRIVE
CRANBURY
NJ
08512
true
Chief Financial Officer
Stock Option (Right to Buy)
56.49
2021-01-04
4
A
0
125000
0
A
2031-01-04
Common Stock
125000
125000
D
The option represents a right to purchase a total of 125,000 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on January 4, 2022, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.
/s/ Sara Turken, as attorney-in-fact
2021-01-06